WebMar 24, 2024 · IRVINE, Calif., March 24, 2024 /PRNewswire/ -- Bioniz Therapeutics, Inc., ("Bioniz"), a clinical-stage biopharmaceutical company advancing a pipeline of first-in-class peptide-based multi-cytokine inhibitors for the treatment of cancer and autoimmune diseases, announced today the appointment of Alexandre Kaoukhov, M.D., as Senior … WebMay 12, 2024 · About Bioniz's Pipeline of Multi-Cytokine Inhibitors Bioniz recently completed a phase 2 study of the Company's lead product candidate, BNZ-1, in cutaneous T-cell lymphoma (CTCL) and is planning a ...
Bioniz Therapeutics Expands Board of Directors and Leadership …
WebJul 20, 2024 · IRVINE, Calif., July 20, 2024 /PRNewswire/ -- Bioniz Therapeutics, Inc., a clinical stage biopharmaceutical company developing first-in-class peptide therapeutics … WebFeb 16, 2024 · Webcast and Conference Call. Management will host a conference call accompanied by a slide presentation to discuss the acquisition of Bioniz for analysts and … how to stiff arm in football
Bioniz Therapeutics - Crunchbase Company Profile & Funding
WebFeb 16, 2024 · Equillium Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates Acquisition includes two... March 26, 2024 ... Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation ... WebDec 5, 2024 · IRVINE, Calif., Dec. 5, 2024 /PRNewswire/ -- Bioniz Therapeutics, Inc., ("Bioniz") today announced positive clinical data in an oral presentation at the 62nd ASH … WebMar 24, 2024 · Mar. 24, 2024, 08:00 AM. IRVINE, Calif., March 24, 2024 /PRNewswire/ -- Bioniz Therapeutics, Inc., ("Bioniz"), a clinical-stage biopharmaceutical company advancing a pipeline of first-in-class ... react strap classname style